Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-371-5 | CAS number: 171171-80-5
Endpoint summary
Administrative data
Description of key information
GLP study utilising registered substance reporting an oral NOAEL of 100 mg/kg/day in the male rat (OECD 408). In the
same study, female rats had an NOAEL of 300 mg/kg/day.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 100 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Additional information
Based on the results of the key study, which tested the registered material, there was a 13% decline in body weights of males at 100 mg/kg/day which did not recover during 28 days of observation. There was no apparent change in any other parameters that could be observed or measured (including histologically), and there were no similar changes in the female rats in the same study. The No Observed Effect Level (NOEL) for oral (gavage) administration of the test material to Crl:CD(SD) rats for 90 consecutive days was 100 mg/kg/day. This is the appropriate value for risk or hazard assessment.
Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
This OECD 408 90d study is the longest exposure duration and the most reliable source of data from which to derive a NOAEL. Based on the results of this study, oral administration of EXP1503090 to Crl:CD(SD) rats at dosage levels of 30, 100, and 300 mg/kg/day for a minimum of 90 consecutive days resulted in adverse, lower body weights (up to 13.9% lower) with corresponding lower food consumption in the 300 mg/kg/day group males. The lower body weights in the 300 mg/kg/day group males were considered to be the key effect and thus the no observed adverse-effect level (NOAEL) was 100 mg/kg/day for males (and 300 mg/kg/day for females). The value for males was taken forward.
Justification for classification or non-classification
The key study described a reasonable dose/concentration above which a degree of toxic effect was acknowledged. The NOAEL derived was 100mg/kg bw/day, so the substance is not considered to require classification under the terms of Directive 67/548/EEC or GHS as reflected by Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
